U.S. markets open in 5 hours 21 minutes
  • S&P Futures

    3,601.00
    -0.50 (-0.01%)
     
  • Dow Futures

    28,857.00
    +56.00 (+0.19%)
     
  • Nasdaq Futures

    10,992.00
    -43.50 (-0.39%)
     
  • Russell 2000 Futures

    1,674.60
    +4.80 (+0.29%)
     
  • Crude Oil

    83.02
    +3.53 (+4.44%)
     
  • Gold

    1,671.60
    -0.40 (-0.02%)
     
  • Silver

    19.33
    +0.29 (+1.53%)
     
  • EUR/USD

    0.9813
    +0.0012 (+0.12%)
     
  • 10-Yr Bond

    3.8040
    0.0000 (0.00%)
     
  • Vix

    32.81
    +0.97 (+3.05%)
     
  • GBP/USD

    1.1204
    +0.0038 (+0.34%)
     
  • USD/JPY

    145.0050
    +0.2760 (+0.19%)
     
  • BTC-USD

    19,184.53
    -106.60 (-0.55%)
     
  • CMC Crypto 200

    435.81
    -7.62 (-1.72%)
     
  • FTSE 100

    6,827.82
    -65.99 (-0.96%)
     
  • Nikkei 225

    26,215.79
    +278.58 (+1.07%)
     

MindMed to Participate in H.C. Wainwright Global Investment Conference

·1 min read

NEW YORK, Sept. 7, 2022 /PRNewswire/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel products to treat brain health disorders, today announced that it will participate virtually at the H.C. Wainwright 24th Annual Global Investment Conference, and its presentation will be available beginning at 7:00 a.m. ET on September 12, 2022.

MindMed stacked logo (PRNewsfoto/Mind Medicine (MindMed) Inc.)
MindMed stacked logo (PRNewsfoto/Mind Medicine (MindMed) Inc.)

For details or to register to attend please visit https://hcwevents.com/annualconference/. A replay of the webcast will be available in the "News & Media" section of MindMed's website.

About MindMed

MindMed is a clinical stage biopharmaceutical company developing novel products to treat brain health disorders. Our mission is to be the global leader in the development and delivery of treatments that unlock new opportunities to improve patient outcomes. We are developing a pipeline of innovative drug candidates, with and without acute perceptual effects, targeting the serotonin, dopamine and acetylcholine systems.

MindMed trades on NASDAQ under the symbol MNMD and on the Canadian NEO Exchange under the symbol MMED.

For Media: media@mindmed.co

For Investors: ir@mindmed.co

 

Cision
Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/mindmed-to-participate-in-hc-wainwright-global-investment-conference-301619002.html

SOURCE Mind Medicine (MindMed) Inc.